ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
101,476.45
0.01%
S&P 500
6,051.09
0.00%
Dow Jones
43,828.06
-0.20%
US Dollar vs Yen
153.735
-0.01%
Brent Oil
74.135
0.00%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. イギリス
  5. LSE
  6. Hikma Pharmaceuticals Plc (HIK)

  7. Hikma Pharmaceuticals Plc (HIK) ニュース

HIK

Hikma Pharmaceuticals (HIK)

Hikma Pharmaceuticals Plc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:LSE:HIK
日付受信時刻ニュースソース見出しコード企業名
2024/11/0800 : 30RNS Regulatory NewsHikma Pharmaceuticals Plc Outcome of Audit Tender ProcessLSE:HIKHikma Pharmaceuticals Plc
2024/11/0719 : 59Alliance NewsAlliance NewsHikma Pharmaceuticals reiterates full-year guidance amid strong growthLSE:HIKHikma Pharmaceuticals Plc
2024/11/0719 : 59Alliance NewsAlliance NewsHikma Pharmaceuticals reiterates full-year guidance amid strong growthLSE:HIKHikma Pharmaceuticals Plc
2024/11/0716 : 00RNS Regulatory NewsHikma Pharmaceuticals Plc Trading StatementLSE:HIKHikma Pharmaceuticals Plc
2024/10/2415 : 00RNS Regulatory NewsHikma Pharmaceuticals Plc 2024 Annual General Meeting Update StatementLSE:HIKHikma Pharmaceuticals Plc
2024/10/0117 : 45RNS Regulatory NewsHikma Pharmaceuticals Plc Block listing Interim ReviewLSE:HIKHikma Pharmaceuticals Plc
2024/09/2418 : 09RNS Regulatory NewsHikma Pharmaceuticals Plc Director/PDMR ShareholdingLSE:HIKHikma Pharmaceuticals Plc
2024/09/1017 : 09Alliance NewsAlliance NewsHikma Pharmaceuticals completes acquisition of Xellia's FDF businessLSE:HIKHikma Pharmaceuticals Plc
2024/09/1017 : 09Alliance NewsAlliance NewsHikma Pharmaceuticals completes acquisition of Xellia's FDF businessLSE:HIKHikma Pharmaceuticals Plc
2024/09/1015 : 00RNS Regulatory NewsHikma Pharmaceuticals Plc Hikma completes Xellia acquisitionLSE:HIKHikma Pharmaceuticals Plc
2024/09/0320 : 46Alliance NewsAlliance NewsIN THE KNOW: Berenberg sees "standout" year at Hikma's Injectibles armLSE:HIKHikma Pharmaceuticals Plc
2024/09/0320 : 46Alliance NewsAlliance NewsIN THE KNOW: Berenberg sees "standout" year at Hikma's Injectibles armLSE:HIKHikma Pharmaceuticals Plc
2024/08/2101 : 15PR Newswire (US)Hikma Pharmaceuticals participates in naloxone training event with U.S. Congressman Buddy Carter ahead of National Fentanyl Awareness and Prevention DayLSE:HIKHikma Pharmaceuticals Plc
2024/08/1604 : 18PR Newswire (US)KLOXXADO® 8mg Naloxone Nasal Spray Shelf-Life Extended from 24 months to 36 monthsLSE:HIKHikma Pharmaceuticals Plc
2024/08/1318 : 16Alliance NewsAlliance NewsIN BRIEF: Hikma executive Bassam Kanaan sells 45,000 sharesLSE:HIKHikma Pharmaceuticals Plc
2024/08/1318 : 16Alliance NewsAlliance NewsIN BRIEF: Hikma executive Bassam Kanaan sells 45,000 sharesLSE:HIKHikma Pharmaceuticals Plc
2024/08/1317 : 39RNS Regulatory NewsHikma Pharmaceuticals Plc Director/PDMR ShareholdingLSE:HIKHikma Pharmaceuticals Plc
2024/08/0819 : 33Alliance NewsAlliance NewsHikma Pharmaceuticals raises guidance as first-half profit jumps 43%LSE:HIKHikma Pharmaceuticals Plc
2024/08/0819 : 33Alliance NewsAlliance NewsHikma Pharmaceuticals raises guidance as first-half profit jumps 43%LSE:HIKHikma Pharmaceuticals Plc
2024/08/0815 : 00RNS Regulatory NewsHikma Pharmaceuticals Plc Half-year ReportLSE:HIKHikma Pharmaceuticals Plc
2024/07/3000 : 08RNS Regulatory NewsHikma Pharmaceuticals Plc Director DeclarationLSE:HIKHikma Pharmaceuticals Plc
2024/07/1515 : 00RNS Regulatory NewsHikma Pharmaceuticals Plc Notice of ResultsLSE:HIKHikma Pharmaceuticals Plc
2024/07/0122 : 47RNS Regulatory NewsHikma Pharmaceuticals Plc Total Voting RightsLSE:HIKHikma Pharmaceuticals Plc
2024/06/2721 : 47RNS Regulatory NewsHikma Pharmaceuticals Plc Director DeclarationLSE:HIKHikma Pharmaceuticals Plc
2024/06/1717 : 14Alliance NewsAlliance NewsHikma adds scale to US injectables business with Xellia acquisitionLSE:HIKHikma Pharmaceuticals Plc
2024/06/1717 : 14Alliance NewsAlliance NewsHikma adds scale to US injectables business with Xellia acquisitionLSE:HIKHikma Pharmaceuticals Plc
2024/06/1715 : 00RNS Regulatory NewsHikma Pharmaceuticals Plc Hikma acquires Xellia’s assetsLSE:HIKHikma Pharmaceuticals Plc
2024/06/1121 : 05Alliance NewsAlliance NewsIN THE KNOW: Citi lifts Hikma price target amid positive industry dataLSE:HIKHikma Pharmaceuticals Plc
2024/06/1121 : 05Alliance NewsAlliance NewsIN THE KNOW: Citi lifts Hikma price target amid positive industry dataLSE:HIKHikma Pharmaceuticals Plc
2024/06/0522 : 53RNS Regulatory NewsHikma Pharmaceuticals Plc Director/PDMR ShareholdingLSE:HIKHikma Pharmaceuticals Plc
 Showing the most relevant articles for your search:LSE:HIK

最近閲覧した銘柄

NASDAQ
IONS
Ionis Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有